Carbon dots as inhibitors of virus by activation of type I interferon response

被引：113

作者：

Du, Ting ^{[1
]}

Liang, Jiangong ^{[1
]}

Dong, Nan ^{[2
]}

Liu, Lin ^{[1
]}

Fang, Liurong ^{[2
]}

Xiao, Shaobo ^{[2
]}

Han, Heyou ^{[1
]}

机构：

[1] Huazhong Agr Univ, Coll Sci, Coll Food Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China

[2] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China

来源：

CARBON | 2016年 / 110卷

基金：

中国国家自然科学基金;

关键词：

QUANTUM DOTS; PSEUDORABIES-VIRUS; ANTIVIRAL ACTIVITY; SILVER NANOPARTICLES; NANODOTS; INFECTION; PROTEIN; SURFACE; CHARGE; ENTRY;

D O I：

10.1016/j.carbon.2016.09.032

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

Carbon dots (CDs) has shown exciting potential in the field of bioscience and biotechnology due to their low toxicity, biological and ecological friendliness and desirable performance characteristics of quantum dots (QDs). However, the effects of CDs on viruses are still largely unknown. In this study, we investigate the effect of CDs on the replication of virus by using pseudorabies virus (PRV) and porcine reproductive and respiratory syndrome virus (PRRSV) as the models of DNA virus and RNA virus, respectively. Analyses of virus titers and the expression of viral proteins demonstrate that cells treated with CDs can significantly inhibit the multiplication of PRV and PRRSV. In mechanism, CDs treatment dramatically induces interferon-alpha (IFN-alpha) production and the expression of IFN-stimulating genes (ISGs) which in turn inhibits virus replication. Taken together, these results reveal a previously undefined role of CDs and provide a new strategy to develop antiviral agents. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：278 / 285

页数：8

共 50 条

[41] Dependence of RIG-I Nucleic Acid-Binding and ATP Hydrolysis on Activation of Type I Interferon Response
Baek, Yu Mi
Yoon, Soojin
Hwang, Yeo Eun
Kim, Dong-Eun
IMMUNE NETWORK, 2016, 16 (04) : 249 - 255
[42] Relative timing of type I interferon response and virus replication determines disease outcome during respiratory virus infection
Channappanavar, Rudragouda
Fehr, Anthony
Zheng, Jian
Abrahante, Juan
Mack, Matthias
Meyerholz, David
Perlman, Stanley
JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
[43] Response of CDA type I to alpha-interferon
Wickramasinghe, SN
EUROPEAN JOURNAL OF HAEMATOLOGY, 1997, 58 (02) : 121 - 123
[44] Dampening of ISGylation of RIG-I by ADAP regulates type I interferon response of macrophages to RNA virus infection
Wang, Yan
Feng, Haixia
Li, Xiao
Ruan, Yina
Guo, Yueping
Cui, Xinxing
Zhang, Pengchao
Li, Yanli
Wang, Xinning
Wang, Xingran
Wei, Luxin
Yi, Yulan
Zhang, Lifeng
Yang, Xiaodong
Liu, Hebin
PLOS PATHOGENS, 2024, 20 (05)
[45] Unraveling the complexity of the type I interferon antiviral response
Schoggins, John W.
Wilson, Sam J.
Panis, Maryline
Murphy, Mary Y.
Jones, Christopher T.
Bieniasz, Paul
Rice, Charles M.
CYTOKINE, 2011, 56 (01) : 48 - 48
[46] Type I interferon response in the central nervous system
Paul, Sophie
Ricour, Celine
Sommereyns, Caroline
Sorgeloos, Frederic
Michiels, Thomas
BIOCHIMIE, 2007, 89 (6-7) : 770 - 778
[47] Induction and evasion of the type I interferon response by cytomegaloviruses
DeFilippis, Victor R.
CURRENT TOPICS IN INNATE IMMUNITY, 2007, 598 : 309 - 324
[48] ULK1 in type I interferon response
Saleiro, Diana
Platanias, Leonidas C.
ONCOTARGET, 2015, 6 (28) : 24586 - 24587
[49] Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA
Steinhagen, Folkert
Meyer, Corinna
Tross, Debra
Gursel, Mayda
Maeda, Takahiro
Klaschik, Sven
Klinman, Dennis M.
JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 92 (04) : 775 - 785
[50] THE ASSOCIATION BETWEEN TYPE I INTERFERON RESPONSE, COMPLEMENT ACTIVATION AND CLINICAL FINDINGS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Sacar, K.
Pamuk, O. N.
Pamuk, G. E.
Uyanik, M. S.
Donmez, S.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 529 - 529

← 1 2 3 4 5 →